What Is the Starting Dose of Semaglutide?
Introduction
The starting dose of semaglutide is 0.25 mg injected subcutaneously once weekly for the first 4 weeks. This applies to both Ozempic® (diabetes) and Wegovy® (weight loss). The 0.25 mg dose isn’t intended to drive weight loss or A1C reductions on its own. It’s a tolerance-building dose that lets your gut adapt to slower stomach emptying.
After 4 weeks at 0.25 mg, you step up to 0.5 mg for another 4 weeks. The schedule then continues to 1.0 mg, 1.7 mg, and 2.4 mg in 4-week increments, depending on indication and tolerance.
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.
Why Does Semaglutide Start at 0.25 Mg?
The 0.25 mg starting dose exists because semaglutide slows gastric emptying. At full therapeutic doses (1.0 to 2.4 mg), the slowdown can be substantial enough to cause nausea, vomiting, reflux, and constipation. Starting low and ramping up gives your gut time to adapt.
Quick Answer: All semaglutide users start at 0.25 mg weekly for the first 4 weeks
In the SUSTAIN and STEP trial designs, the 4-week-per-step schedule cut early discontinuation rates significantly. Patients who started at higher doses had double or triple the GI side effects and quit at much higher rates.
That 0.25 mg pre-step is the difference between a drug most people can tolerate and one a third of users would abandon in month one.
Will I Lose Weight on the 0.25 Mg Starting Dose?
A small amount, maybe. The mean weight loss at week 4 in STEP 1 was about 2.5%, vs roughly 1% on placebo. So semaglutide users averaged about a 1.5% advantage from the 0.25 mg dose alone, which is roughly 3 pounds for a 200-pound starting weight.
Most of that effect comes from appetite suppression and reduced caloric intake, not direct metabolic effects. Some patients feel substantial appetite reduction even at 0.25 mg, while others feel almost nothing until 0.5 or 1.0 mg.
If the scale hasn’t moved at all by week 4, that’s normal. The real weight loss curve typically kicks in around weeks 9 to 16 as you reach 1.0 mg or higher.
What Is the Full Semaglutide Titration Schedule?
For Wegovy (weight loss), the standard escalation is: 0.25 mg weeks 1-4, 0.5 mg weeks 5-8, 1.0 mg weeks 9-12, 1.7 mg weeks 13-16, 2.4 mg week 17 onward. The full ramp takes 16 weeks to reach maintenance.
For Ozempic (type 2 diabetes), the schedule is the same through 1.0 mg, with optional escalation to 2.0 mg if A1C control needs more help. Some patients stay at 0.5 or 1.0 mg long-term if their A1C is well controlled.
Compounded semaglutide through TrimRx follows the same pharmacologic schedule but uses vials and syringes rather than pre-filled pens, which gives more flexibility in dose precision and titration timing.
What If 0.25 Mg Is Too Much?
Some patients tolerate even 0.25 mg poorly, with persistent nausea, vomiting, or severe loss of appetite that interferes with normal eating. In those cases, options include extending the 0.25 mg step to 6 or 8 weeks before moving up, lowering the effective dose with a half-dose protocol (used with compounded semaglutide), and trialing anti-nausea support like ondansetron during meals.
For severe intolerance, switching to oral semaglutide (Rybelsus®) is sometimes considered, though oral semaglutide has its own GI profile. Tirzepatide isn’t a fix for semaglutide intolerance because the GI effects are similar.
Roughly 5 to 10% of patients can’t tolerate any GLP-1 even after slow titration. For them, mechanism-different drugs like phentermine-topiramate, naltrexone-bupropion, or bariatric surgery may be better options.
Key Takeaway: Standard titration adds 4 weeks per step: 0.25 to 0.5 to 1.0 to 1.7 to 2.4 mg
Can I Skip the Starting Dose If I Tolerate Medications Well?
No, and providers won’t prescribe it that way. Starting at 0.5 mg or higher is associated with significantly more nausea and vomiting regardless of how well you tolerate other drugs. GLP-1 GI side effects depend on the drug’s mechanism, not your general drug tolerance.
There’s also no proven benefit to starting higher. Skipping 0.25 mg doesn’t speed up your overall weight loss. The drug needs time to reach steady state regardless (the 7-day half-life means about 5 weeks to reach equilibrium), and titration timing is calibrated to that.
If you’ve been on semaglutide before, stopped for less than 6 weeks, and want to restart, your provider may let you resume at your previous dose. If you’ve been off longer than 6 weeks, re-titration from 0.25 mg is the default.
How Do I Inject the 0.25 Mg Dose?
For Ozempic and Wegovy pens, the dose dial is set to the prescribed dose (0.25 mg in this case) and the injection is given subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites week to week to avoid skin issues.
For compounded semaglutide from a pharmacy, you’ll draw the dose into a syringe based on the concentration. Common compounded concentrations are 2.5 mg/mL (so 0.25 mg = 0.1 mL) or 5 mg/mL (so 0.25 mg = 0.05 mL). Always check the label and the provider’s instructions.
Inject at a 90-degree angle into pinched skin. The needles are short (4 to 8 mm) and the injection is largely painless. Best practice: pre-injection alcohol wipe, fresh needle each time, and a sharps container for disposal.
When Do You Move Past the Starting Dose?
The standard move from 0.25 mg to 0.5 mg happens at week 5 if side effects are manageable. “Manageable” means nausea no worse than mild and intermittent, no persistent vomiting, no severe reflux, and adequate hydration and nutrition.
If you’re still having significant GI issues at week 4, holding at 0.25 mg for another 2 to 4 weeks is reasonable and won’t compromise your long-term results. Some patients benefit from a longer ramp at every step, taking 5 or 6 months to reach 2.4 mg instead of the standard 4.
The TrimRx personalized treatment plan tracks side effects week-by-week and adjusts the titration timing based on what you’re actually experiencing, not a one-size schedule.
Bottom line: Ozempic maxes at 2.0 mg for T2D, Wegovy maxes at 2.4 mg for weight loss
FAQ
Is 0.25 Mg of Semaglutide Enough to Lose Weight?
For most people, no. The 0.25 mg dose produces about 1 to 3% weight loss on average, which isn’t clinically meaningful for obesity. Significant weight loss typically requires reaching 1.0 mg or higher. Some unusually sensitive responders do see real weight loss at 0.25 mg, but they’re the exception.
Can I Stay at 0.5 Mg Long-term?
Yes, for diabetes. For weight loss, 0.5 mg is typically a step on the way to 1.7 or 2.4 mg, since the higher doses produce more weight loss in trials. Some weight-loss patients stay at 0.5 or 1.0 mg if they’re already achieving good results without side effects.
What’s the Maximum Dose of Semaglutide?
The FDA-approved maximums are 2.0 mg weekly for Ozempic (T2D) and 2.4 mg weekly for Wegovy (obesity). Higher doses haven’t been studied for safety in approved indications. Some clinical trials have tested 3.0 mg and higher experimentally, but these are not standard of care.
How Long Until I Notice the 0.25 Mg Dose Working?
Appetite suppression often shows up in the first week, with a peak 24 to 72 hours after the injection. Visible scale changes usually take 4 to 8 weeks even in responders, since the starter dose isn’t pushing hard on calorie intake.
Does the Starting Dose Still Help Me Even If I Don’t Feel It?
Yes. The 0.25 mg dose is building up plasma levels and giving your gut time to adapt. Even if you don’t feel appetite suppression, the drug is preparing your system for the higher doses that will drive weight loss. Don’t quit because the starter dose feels like nothing.
Can I Take 0.25 Mg Every Two Weeks Instead of Weekly?
No. The drug’s pharmacokinetics require weekly dosing to maintain steady blood levels. Every-two-weeks dosing produces big peaks and troughs that worsen side effects and reduce efficacy. Stick to the once-weekly schedule on the same day each week.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.
Transforming Lives, One Step at a Time
Keep reading
Semaglutide Molecule Explained: Why It Lasts a Week
Introduction Semaglutide lasts about a week in the body because it is engineered to cling to a blood protein called albumin and to resist…
Semaglutide MASH Approval: What ESSENCE Data Means
The 2026 FDA approval of semaglutide for MASH is a genuine milestone in liver medicine, and the ESSENCE trial is the data behind it.
Mazdutide vs Semaglutide: Head-to-Head Trial Data
Introduction Mazdutide adds a glucagon target to the GLP-1 mechanism that semaglutide uses alone, which in theory should drive more fat loss and better…